ODTC Financials: Odonate Inc AI Analysis

Home

Stock

ODTC

Financials

ODTC Financial

Odonate Inc

0%

$0

At close: Mar 24, 16:00:00 GMT-4

0%

$0

Post-market: Mar 24, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is ODTC?

Odonate, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improve and extend the lives of patients with cancer. The company is headquartered in San Diego, California and currently employs 137 full-time employees. The company went IPO on 2017-12-07. The firm is focused on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The firm is no longer in development of tesetax.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

ODTC Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	19	10	10	10	4	0
Research & Development	71	117	104	79	27	2
Operating Expenses	90	127	114	90	32	3
Other Non Operating Income (Expenses)	0	1	--	--	--	--
Pretax Income	-102	-126	-111	-88	-32	-3
Income Tax Expense	--	--	--	--	--	0
Net Income	-102	-126	-111	-88	-32	-3
Net Income Growth	-16%	14%	26%	175%	967%	--
Shares Outstanding (Diluted)	0.94	0.82	0.69	0.61	0.67	0.66
Shares Change (YoY)	16%	19%	13%	-9%	1%	0%
EPS (Diluted)	-107.65	-153.79	-161.91	-145.46	-48.7	-4.65
EPS Growth	-28%	-5%	11%	199%	947%	1,922%
Free Cash Flow	-94	-113	-96	-69	-25	-1
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-90	-127	-114	-90	-32	-3
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-90	-127	-114	-90	-32	-3
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	0%

Follow-Up Questions

What are Odonate Inc's key financial statements?



According to the latest financial statement (Form-10K), Odonate Inc has a total asset of $167, Net loss of $-126

What are the key financial ratios for ODTC?



Odonate Inc's Current ratio is 5.38, has a Net margin is 0, sales per share of $0.

How is Odonate Inc's revenue broken down by segment or geography?



Odonate Inc largest revenue segment is System, at a revenue of 130,433,000,000 in the most earnings release.For geography, Japan is the primary market for Odonate Inc, at a revenue of 404,010,000,000.

Is Odonate Inc profitable?



no, according to the latest financial statements, Odonate Inc has a net loss of $-126

Does Odonate Inc have any liabilities?



yes, Odonate Inc has liability of 31

How many outstanding shares for Odonate Inc?



Odonate Inc has a total outstanding shares of 0.96

Odonate Inc (ODTC) Financial

ODTC Stock Price Chart